4.6 Article

TRIM11 cooperates with HSF1 to suppress the anti-tumor effect of proteotoxic stress drugs

Journal

CELL CYCLE
Volume 18, Issue 1, Pages 60-68

Publisher

TAYLOR & FRANCIS INC
DOI: 10.1080/15384101.2018.1558870

Keywords

Proteotoxic stress; TRIM11; cell viability; anti-tumor; HSF1

Categories

Funding

  1. National Institutes of Health [R01CA182675, R01CA184867]
  2. National Natural Science Foundation of China [31801186]
  3. Wealth Strategy Holding Limited

Ask authors/readers for more resources

Cells mainly rely on stress proteins, such as heat-shock proteins (HSPs), to respond to various proteotoxic conditions. These proteins protect tumor cells and enhance their survive. However, the regulation of stress proteins involved in protein quality control (PQC) is still poorly understood. Here, we report that the expression of TRIM11, an important regulator of PQC, is positively correlated with tumor cell surviaval during the proteotoxic conditions induced by anti-tumor drugs. In addition, HSF1 is required for TRIM11-mediated removal of protein aggregates and resistance of proteotoxic stress. During these processes, TRIM11 interacts with and stabilizes HSF1, increaseing HSF1 levels in the nucleus. These findings identify that TRIM11, through cooperation with HSF1, protects cells against the proteotoxic stress and promotes tumor cell survival.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Biochemistry & Molecular Biology

Cab45S promotes cell proliferation through SERCA2b inhibition and Ca2+ signaling

L. Chen, S. Xu, Y. Xu, W. Lu, L. Liu, D. Yue, J. Teng, J. Chen

ONCOGENE (2016)

Article Cell Biology

Enhanced Degradation of Misfolded Proteins Promotes Tumorigenesis

Liang Chen, Michael D. Brewer, Lili Guo, Ruoxing Wang, Peng Jiang, Xiaolu Yang

CELL REPORTS (2017)

Article Multidisciplinary Sciences

TRIM11 activates the proteasome and promotes overall protein degradation by regulating USP14

Liang Chen, Guixin Zhu, Eleanor M. Johns, Xiaolu Yang

NATURE COMMUNICATIONS (2018)

Article Cell Biology

Cab45S inhibits the ER stress-induced IRE1-JNK pathway and apoptosis via GRP78/BiP

L. Chen, S. Xu, L. Liu, X. Wen, Y. Xu, J. Chen, J. Teng

CELL DEATH & DISEASE (2014)

Article Multidisciplinary Sciences

TRIM25 promotes the cell survival and growth of hepatocellular carcinoma through targeting Keap1-Nrf2 pathway

Yanfeng Liu, Shishi Tao, Lijuan Liao, Yang Li, Hongchang Li, Zhihuan Li, Lilong Lin, Xiaochun Wan, Xiaolu Yang, Liang Chen

NATURE COMMUNICATIONS (2020)

Article Cell Biology

LHPPinhibits hepatocellular carcinoma cell growth and metastasis

Lijuan Liao, Deyu Duan, Yanfeng Liu, Liang Chen

CELL CYCLE (2020)

Article Oncology

TRIM28 attenuates Bortezomib sensitivity of hepatocellular carcinoma cells through enhanced proteasome expression

Jianchao Zhang, Xiaokai Fan, Lijuan Liao, Yan Zhu, Xiaochun Wan, Hai Rao, Liang Chen

CLINICAL AND TRANSLATIONAL MEDICINE (2022)

Letter Oncology

Inhibition of AMPK activity by TRIM11 facilitates cell survival of hepatocellular carcinoma under metabolic stress

Yanfeng Liu, Yingying Xu, Fan Wang, Yu Tong, Hongchang Li, Xiaochun Wan, Xiaolu Yang, Liang Chen

CLINICAL AND TRANSLATIONAL MEDICINE (2021)

Review Biochemistry & Molecular Biology

TRIM family proteins: roles in proteostasis and neurodegenerative diseases

Yan Zhu, Lukman O. Afolabi, Xiaochun Wan, Joong Sup Shim, Liang Chen

Summary: Neurodegenerative diseases are characterized by the degeneration of the central or peripheral nervous systems and the aggregation of misfolded proteins, leading to cellular dysfunction and brain damage. TRIM proteins play important roles in maintaining protein quality control and clearing misfolded protein aggregates associated with neurodegenerative diseases.

OPEN BIOLOGY (2022)

Article Oncology

TRIM59 guards ER proteostasis and prevents Bortezomib-mediated colorectal cancer (CRC) cells' killing

Xuejia Feng, Gui Yang, Litian Zhang, Shishi Tao, Joong Sup Shim, Liang Chen, Qingxia Wu

Summary: This study identified the role of tripartite motif-containing protein 59 (TRIM59) in preventing drug resistance in colorectal cancer (CRC) cells treated with Bortezomib (BTZ). Depletion of TRIM59 enhances endoplasmic reticulum stress and unfolded protein response (UPR) signaling, while also strengthening endoplasmic reticulum-associated degradation (ERAD) and alleviating ROS generation. Knockdown of TRIM59 synergizes with the anti-cancer effect of BTZ both in vitro and in vivo.

INVESTIGATIONAL NEW DRUGS (2022)

Review Immunology

Exploiting the CRISPR-Cas9 gene-editing system for human cancers and immunotherapy

Lukman O. Afolabi, Mariam O. Afolabi, Musbahu M. Sani, Wahab O. Okunowo, Dehong Yan, Liang Chen, Yaou Zhang, Xiaochun Wan

Summary: The use of CRISPR-Cas9 technology in cancer research and treatment, particularly in immunotherapy, has shown great potential for innovative cell design and therapy. This technology enables the creation of advanced engineered immune cells with enhanced functionality for better sensing and targeting of tumors.

CLINICAL & TRANSLATIONAL IMMUNOLOGY (2021)

No Data Available